Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Bupivacaine Mixture for Skin Numbing
NCT01243112Phase 4Completed
- Sponsor
- Baylor Scott & White Health
- Start
- May 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine, bupivacaine in pain, sponsored by Baylor Scott & White Health. Started May 2010; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01243112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243112.